Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Global Medical REIT Inc (NYSE: GMRE) closed at $7.59 down -1.68% from its previous closing price of $7.72. In other words, the price has decreased by -$1.68 from its previous closing price. On the day, 0.55 million shares were traded. GMRE stock price reached its highest trading level at $7.74 during the session, while it also had its lowest trading level at $7.52.
Ratios:
For a deeper understanding of Global Medical REIT Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 57.81 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.28. In the meantime, Its Debt-to-Equity ratio is 1.18 whereas as Long-Term Debt/Eq ratio is at 1.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Berenberg on October 18, 2024, initiated with a Buy rating and assigned the stock a target price of $11.75.
On September 19, 2024, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $12.
Robert W. Baird Downgraded its Outperform to Neutral on October 10, 2022, while the target price for the stock was maintained at $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GMRE now has a Market Capitalization of 524097088 and an Enterprise Value of 1219779456. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.55 while its Price-to-Book (P/B) ratio in mrq is 1.08. Its current Enterprise Value per Revenue stands at 8.931 whereas that against EBITDA is 14.059.
Stock Price History:
Over the past 52 weeks, GMRE has reached a high of $11.12, while it has fallen to a 52-week low of $7.43. The 50-Day Moving Average of the stock is -12.19%, while the 200-Day Moving Average is calculated to be -15.36%.
Shares Statistics:
For the past three months, GMRE has traded an average of 406.47K shares per day and 739090 over the past ten days. A total of 66.80M shares are outstanding, with a floating share count of 63.03M. Insiders hold about 5.65% of the company’s shares, while institutions hold 61.49% stake in the company. Shares short for GMRE as of 1734048000 were 1054011 with a Short Ratio of 2.59, compared to 1731628800 on 1043559. Therefore, it implies a Short% of Shares Outstanding of 1054011 and a Short% of Float of 1.67.
Dividends & Splits
According to the company, the forward annual dividend rate for GMRE is 0.84, from 0.84 in the trailing year. Against a Trailing Annual Dividend Yield of 0.10880829The stock’s 5-year Average Dividend Yield is 7.44.
